Lexington, Mass.-based Cubist Pharmaceuticals has issued a voluntary recall of one lot of CUBICIN, an intravenously administered antibiotic, due to glass particles found in a single vial from this lot.
The matter was reported by a customer complaint.
Presence of glass particulate in an intravenous drug presents a risk for thromboembolism, mechanical blocking of capillaries or arterioles and tissue inflammation. Patients with preexisting conditions of trauma or other conditions that affect the microvascular blood supply are at an increased risk for an adverse event.
No adverse events have yet been reported in association with this issue.
More Articles on Recalls:
Hospira Recalls Propofol Injectable Emulsion, USP
Covidien Recalls Pipeline Embolization Device, Alligator Retrieval Device
What the Increase in Device Recalls Means for Hospitals